![](/img/cover-not-exists.png)
Single agent oral topotecan (OT) as first-line treatment for patients (pts) with extensive disease (ED) small cell lung cancer (SCLC) ineligible for standard therapy: A phase II study
Eckardt, J.R, Palmer, M.C, Fanucchi, M.P, Gralla, R, Martins, H, Poulin, R, Fields, S.ZVolume:
29
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(00)80025-2
Date:
September, 2000
File:
PDF, 113 KB
english, 2000